Cargando…

Factors Influencing the Duration of Termination of Pregnancy for Fetal Anomaly with Mifepristone in Combination with Misoprostol

This study’s aim was to determine relevant factors that influence the time interval between first induction and fetal expulsion in late termination of pregnancy (TOP) and TOP after previous feticide for severe fetal malformation with a mifepristone–misoprostol regime. This retrospective study includ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reischer, Theresa, Limbach, Iris, Catic, Anja, Niedermaier, Katrin, Falcone, Veronica, Yerlikaya-Schatten, Gülen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918131/ https://www.ncbi.nlm.nih.gov/pubmed/36769518 http://dx.doi.org/10.3390/jcm12030869

Ejemplares similares

Clinical Course and Outcome of Non-Immune Fetal Hydrops in Singleton Pregnancies
por: Reischer, Theresa, et al.
Publicado: (2022)

Clinical Factors for Predicting Pharmacotherapy in Twin Pregnancies Complicated by Gestational Diabetes Mellitus
por: Catic, Anja, et al.
Publicado: (2023)

Mifepristone and Misoprostol vs Misoprostol Alone in Second Trimester Termination of Pregnancy
por: Shah, Deepa, et al.
Publicado: (2018)

Simpson-Golabi-Behmel-Syndrome in Dichorionic-Diamniotic Twin Pregnancy
por: Reischer, Theresa, et al.
Publicado: (2021)

Clinical Course and Outcome of Prenatally Detected 22q11.2 Deletion Syndrome—A Retrospective Analysis
por: Paternostro, Chiara, et al.
Publicado: (2023)

Mifepristone and Misoprostol for Undesired Pregnancy of Unknown Location
por: Goldberg, Alisa B., et al.
Publicado: (2022)

Role of Combination OF Mifepristone and Misoprostol Verses Misoprostol alone in Induction of Labour in Late Intrauterin Fetal Death: A Prospective Study
por: Panda, Subrat, et al.
Publicado: (2013)

Medical termination for pregnancy in early first trimester (≤ 63 days) using combination of mifepristone and misoprostol or misoprostol alone: a systematic review
por: Abubeker, Ferid A., et al.
Publicado: (2020)

Singleton exome sequencing of 90 fetuses with ultrasound anomalies revealing novel disease-causing variants and genotype–phenotype correlations
por: Smogavec, Mateja, et al.
Publicado: (2022)

Outcome of Fetal Dysrhythmias with and without Extracardiac Anomalies
por: Springer, Stephanie, et al.
Publicado: (2023)

Implementing medical abortion with mifepristone and misoprostol in Norway 1998–2013
por: Løkeland, Mette, et al.
Publicado: (2017)

Comparing telemedicine to in-clinic medication abortions induced with mifepristone and misoprostol
por: Wiebe, Ellen R, et al.
Publicado: (2020)

Comparison of two doses and two routes of administration of misoprostol after pre-treatment with mifepristone for early pregnancy termination
por: von Hertzen, Helena, et al.
Publicado: (2008)

Prenatal detection of right aortic arch
por: Yerlikaya, Gülen, et al.
Publicado: (2019)

Economic evaluation of a randomized controlled trial comparing mifepristone and misoprostol with misoprostol alone in the treatment of early pregnancy loss
por: Hamel, Charlotte C., et al.
Publicado: (2022)

Comparison of mifepristone plus misoprostol with misoprostol alone for first trimester medical abortion: A systematic review and meta-analysis
por: Shimels, Tariku, et al.
Publicado: (2023)

Medical abortion with mifepristone and home administration of misoprostol up to 63 days’ gestation
por: Løkeland, Mette, et al.
Publicado: (2014)

Early medical abortion with self‐administered low‐dose mifepristone in combination with misoprostol
por: Song, Li‐Ping, et al.
Publicado: (2018)

Clinical Efficacy and Safety Study of Mifepristone with Misoprostol Treatment in Patients with Missed Abortion
por: Zhao, Xiaoying, et al.
Publicado: (2021)

Dutch GPs’ views on prescribing mifepristone and misoprostol: a mixed-methods study
por: Schellekens, Julia EAP, et al.
Publicado: (2022)

Retracted: Clinical Efficacy and Safety Study of Mifepristone with Misoprostol Treatment in Patients with Missed Abortion
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trial
por: Chu, Justin J, et al.
Publicado: (2020)

Oral toxicity of isotretinoin, misoprostol, methotrexate, mifepristone and levonorgestrel as pregnancy category X medications in female mice
por: KIM, SEONG-KWAN, et al.
Publicado: (2015)

Cost of goods sold analysis and recommendations to reduce costs of co-packaged mifepristone–misoprostol for medical abortion
por: Chinery, Lester, et al.
Publicado: (2020)

Mifepristone-misoprostol combination treatment for early pregnancy loss after embryo transfer: a case series
por: Esposito, Leah, et al.
Publicado: (2023)

A Retrospective Cost-Effectiveness Analysis of Mifepristone–Misoprostol Medical Abortions in the First Year at the Regina General Hospital
por: Hunter, Caitlin, et al.
Publicado: (2021)

Mifepristone followed by misoprostol compared with placebo followed by misoprostol as medical treatment for early pregnancy loss (the Triple M trial): A double-blind placebo-controlled randomised trial
por: Hamel, Charlotte, et al.
Publicado: (2021)

Mifepristone and misoprostol versus misoprostol alone for uterine evacuation after early pregnancy failure: study protocol for a randomized double blinded placebo-controlled comparison (Triple M Trial)
por: van den Berg, Joyce, et al.
Publicado: (2019)

Early Assessment of the Risk for Gestational Diabetes Mellitus: Can Fasting Parameters of Glucose Metabolism Contribute to Risk Prediction?
por: Falcone, Veronica, et al.
Publicado: (2019)

Risk-adapted management for vasa praevia: a retrospective study about individualized timing of caesarean section
por: Yerlikaya-Schatten, Gülen, et al.
Publicado: (2019)

Low dose Mifepristone (100 mg) for medical termination of pregnancy
por: Seth, Shikha, et al.
Publicado: (2011)

Recurrence of Gestational Diabetes Mellitus: To Assess Glucose Metabolism and Clinical Risk Factors at the Beginning of a Subsequent Pregnancy
por: Kotzaeridi, Grammata, et al.
Publicado: (2021)

Diagnostic value of fetal autopsy after early termination of pregnancy for fetal anomalies
por: Peyronnet, Violaine, et al.
Publicado: (2022)

Bleeding pattern after medical management of early pregnancy loss with mifepristone–misoprostol and its prognostic value: a prospective observational cohort study
por: Enzelsberger, Simon-Hermann, et al.
Publicado: (2021)

Termination of pregnancy for fetal anomalies: Parents' preferences for psychosocial care
por: Dekkers, Frederike H.W., et al.
Publicado: (2019)

Misoprostol and termination of pregnancy: is there a need for ultrasound screening in a general population to assess the risk for adverse outcome in cases of uterine anomaly?
por: van der Veen, N. M., et al.
Publicado: (2010)

Comparison of Sublingual and Vaginal Misoprostol for Second-Trimester Pregnancy Terminations
por: Milani, Forozan, et al.
Publicado: (2014)

Misoprostol Alone or in Combination with Methotrexate for Termination of Pregnancy at First Trimester
por: Vahid Roudsari, Fatemeh, et al.
Publicado: (2010)

Enhanced expression of the stemness-related factors OCT4, SOX15 and TWIST1 in ectopic endometrium of endometriosis patients
por: Proestling, Katharina, et al.
Publicado: (2016)

Retrospective clinical evaluation of indications for termination of pregnancies due to fetal anomaly
por: Koşar Can, Özlem, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dpd5gvaik1ij3e2r12f19t9efd